Did Angus King sell Teva Pharmaceutical Industries stock?
Independent · U.S. Senate · Maine
Latest filing Nov 10, 2016
Yes. Angus King disclosed 1 sale of Teva Pharmaceutical Industries (TEVA) stock on Oct 19, 2016, in STOCK Act reports. Added together, the disclosed ranges come to $1K-$15K.
Every Teva Pharmaceutical Industries trade
Angus King trades in Teva Pharmaceutical Industries
Did Angus King sell Teva Pharmaceutical Industries stock?
Yes. Angus King disclosed 1 sale of Teva Pharmaceutical Industries (TEVA) stock on Oct 19, 2016, in STOCK Act reports. Added together, the disclosed ranges come to $1K-$15K.
How big were Angus King's Teva Pharmaceutical Industries trades?
STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $1K-$15K.
Did Angus King make these Teva Pharmaceutical Industries trades personally?
Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.
Does Angus King still own Teva Pharmaceutical Industries stock?
This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.
When did Angus King report these trades?
The latest filing is dated Nov 10, 2016. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.
Where does this data come from?
From periodic transaction reports filed under the STOCK Act with the Secretary of the Senate. Every trade links to the original filing.
Reported trades and amount ranges, not what is held today. Reports can include a spouse and dependent children.
Loading